NCT03036319 Patient-Centered NeuroRehabilitation (PCN)
| NCT ID | NCT03036319 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Cognitive Deficit |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2016-06 |
| Primary Completion | 2027-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2016-06 with a primary completion date of 2027-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
As individuals grow older, a number of factors can reduce our cognitive (or thinking) abilities such as "normal" aging, neurodegenerative diseases, and cardiovascular disease. This study will evaluate whether cognitive rehabilitation and transcranial electrical stimulation (TES) can improve cognitive abilities. Cognitive rehabilitation refers to methods that are used to improve tasks people have trouble doing in everyday life. Transcranial electrical stimulation uses small amounts of electricity to try to alter brain functioning. These approaches may help improve cognitive abilities like attention, learning, memory, finding words, and problem solving as well as everyday functioning. The goal of this study is to identify how to best use these methods, either alone or in combination.
Eligibility Criteria
Inclusion Criteria: 1. Individuals who have reported cognitive dysfunction and cognitively intact participants. 2. Participants will be age 50 or older Exclusion Criteria: 1. A history of epilepsy 2. Sensory or motor impairments that limit the ability to take part in the study 3. Current alcohol or drug abuse/dependence 4. Those who are currently pregnant or may become pregnant during the duration of the study (if there is a question of pregnancy, pregnancy tests will be available for participants at no charge) Those who are being evaluated for TES methodology will also be excluded for 1) metallic or electronic implant 2) skull plates or other cranial implants that affect TES
Contact & Investigator
Benjamin M Hampstead, Ph.D.
PRINCIPAL INVESTIGATOR
University of Michigan
Frequently Asked Questions
Who can join the NCT03036319 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Cognitive Deficit. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03036319 currently recruiting?
Yes, NCT03036319 is actively recruiting participants. Contact the research team at krinna@med.umich.edu for enrollment information.
Where is the NCT03036319 trial being conducted?
This trial is being conducted at Ann Arbor, United States.
Who is sponsoring the NCT03036319 clinical trial?
NCT03036319 is sponsored by University of Michigan. The principal investigator is Benjamin M Hampstead, Ph.D. at University of Michigan. The trial plans to enroll 500 participants.